NDC 23155-290
Amikacin Sulfate 250 mg per 1 mL injection, solution
On the label: Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Emcure Pharmaceuticals Limited | Ahmedabad, India | Makes it, tests it, packages it and labels it | Problems found, fixed voluntarilyMay 15, 2026 · 3 inspections |
Recalls
- May 21, 2019 · Class I · Heritage Pharmaceuticals, Inc.
Non-Sterility:Microbial growth detected in sub lot of Amikacin Sulfate Injection, USP 1gm/4 mL (250mg/mL) and Prochlorperazine Edisylate Injection, USP 10mg/2mL (5mg/mL) .
Lots: Lot: VEAC025, EXP 10-2019
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Amikacin: every company that makes it
- Form
- injection, solution, intramuscular; intravenous
- Strength
- 250 mg per 1 mL
- Approval
- ANDA ANDA204040
- On the market since
- Dec 24, 2013
- Package NDCs
23155-290-3123155-290-3223155-290-4123155-290-42- Official label
- DailyMed (National Library of Medicine), updated Jun 18, 2025
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?